PRESS DIGEST- New York Times business news - Feb 5
Feb 5 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.
- U.S. President Donald Trump declared on Tuesday that the United States should seize control of Gaza and permanently displace the entire Palestinian population of the devastated seaside enclave.
- The United States Postal Service said on Tuesday that it had temporarily stopped accepting packages from China and Hong Kong, hours after an order by President Trump took effect that ended duty-free handling of these parcels.
- The U.S. Securities and Exchange Commission is moving to scale back a special unit of more than 50 lawyers and staff members that had been dedicated to bringing crypto enforcement actions.
- U.S. President Donald Trump signed an executive order on Tuesday calling for a general review of U.S. funding and involvement in the United Nations, casting uncertainty on the leadership role the United States has played as the global body's top donor.
Related Articles
Team Google Beats Team OpenAI This Round—What It Means for Your Portfolio
TradingKey - Over the past month, AI-related market flows have diverged. Since the launch of Gemini 3, Alphabet’s stock has rallied sharply—while names tied to OpenAI’s ecosystem have come under pressure. Investors are shifting exposure toward companies aligned with Google, especially Broadcom (AVGO
Rivian Stock Analysis: Q3 Earnings Exceed Expectations – Is Now the Time to Buy RIVN Stock?
TradingKey - Emerging EV company Rivian (Nasdaq: RIVN), once considered a "Tesla killer", reported better-than-expected Q3 earnings in November 2025, leading to a monthly stock surge of over 30%. Is buying Rivian a good choice now? Can Rivian's stock reclaim its former heights?
Novo Nordisk (NVO) : From Market Darling to Selloff Target — Should You Buy the Dip?
TradingKey - We've recently observed that,Novo Nordisk A/S, impacted by intensifying competition in weight-loss drugs (such as from U.S.Eli Lilly and Company) and weaker-than-expected earnings reports, has seen its stock price continually decline, falling over 70% from its peak of 143.54.
Why Did Strategy's Stock Price Plummet? Can MSTR Reach $1,000?
MicroStrategy (MSTR) stock, despite pressures from Bitcoin volatility and its weak core business, represents the most leveraged investment in a Bitcoin bull market. The company's stock path to $1,000 largely depends on Bitcoin's market performance. Major institutions, including Standard Chartered an
U.S. September PCE: Likely to Fall Short of Expectations, Bullish for US Stocks
TradingKey - Currently, the market widely anticipates that the core PCE year-on-year growth rate for September will stand at 2.9%, and we expect the upcoming data to be slightly below this consensus forecast.
